Measuring ocular biomechanics with a new Scheimpflug-based device

Article

The CorVis ST, a new Scheimpflug-based device, has the potential to analyze ocular biomechanical properties for further research. Here, Dr Nemeth discusses his recent study analyzing the repeatability of data obtained with this new device.

Until recently, the only device for conducting in vivo measurements of ocular biomechanics has been the Ocular Response Analyzer (ORA, Reichert Ophthalmic Instruments, Depew, New York, USA). Recently, a new Scheimpflug-based device, named CorVis ST (Corneal Visualization Scheimpflug Technology, CorVis ST, Oculus Inc., Wetzlar, Germany) was introduced for measuring new ocular biomechanical properties.

The Ocular Response Analyzer

The biomechanics of the cornea is described using two main sets of data as measured by ORA. During the deformation period, the device records two applanation pressure measurements and the difference between these two values are called corneal hysteresis. The ORA calculates another value, the corneal resistance factor; in addition, the latest software provides further numerical information, too.

The CorVis ST

During these three phases, ten so-called 'device-specific parameters' are recorded: maximum deformation amplitude [the highest concavity (HC) of the cornea], time taken to reach it, time of the first and second applanation, length of the flattened cornea at the first and second applanation, maximum corneal velocity during the first and second applanation phase, peak distance, which is the distance of the two apex (knees) at highest concavity and a radius value, which represents the central concave curvature at HC.

Besides the above described ten parameters, central corneal thickness (CCT) and intraocular pressure (IOP) based on the first applanation is also determined by CorVis ST.

Recent Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Marjorie Rah, OD, PhD, FAAO
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
Josefina Botta, MD, MSc, at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.